{"id":"placebo-of-perindopril-p1","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL1581","moleculeType":"Small molecule","molecularWeight":"368.47"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. It is used as a control in clinical trials to compare against the active drug (perindopril in this case) and to assess the placebo response independent of the drug's mechanism.","oneSentence":"This is a placebo formulation with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:22.185Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT00128518","phase":"PHASE4","title":"IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2004-10","conditions":"Hypertension","enrollment":139}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo of Perindopril (P1)","genericName":"Placebo of Perindopril (P1)","companyName":"Hospices Civils de Lyon","companyId":"hospices-civils-de-lyon","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}